OpASHA : Improving Tuberculosis Treatment and Outcomes

Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world’s total burden. To control TB, complete adherence to treatment is crucial—under the World Health Organization’s (WHO) Directly Observed Therapy...

Full description

Bibliographic Details
Main Authors:	Agapitova, Natalia, Navarrete Moreno, Cristina
Format:	Case Study
Language:	English en_US
Published:	World Bank, Washington, DC 2017
Subjects:	TUBERCULOSIS HEALTH TREATMENT MEDICINES DISEASES DIABETES
Online Access:	http://documents.worldbank.org/curated/en/761511495104055640/OpASHA-improving-tuberculosis-treatment-and-outcomes http://hdl.handle.net/10986/27665

id	okr-10986-27665
recordtype	oai_dc
spelling	okr-10986-276652021-05-25T09:01:07Z OpASHA : Improving Tuberculosis Treatment and Outcomes Agapitova, Natalia Navarrete Moreno, Cristina TUBERCULOSIS HEALTH TREATMENT MEDICINES DISEASES DIABETES Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world’s total burden. To control TB, complete adherence to treatment is crucial—under the World Health Organization’s (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this strategy, patients are required to take up to 75 doses under supervision over six months at a treatment center or in the presence of an observer. However, the scarcity or inaccessibility of treatment centers and truthful observers in hard to-reach areas often results in high default rates. Missing a dose or interrupting treatment is extremely dangerous, since those who default can relapse, or much worse, develop the deadlier, drug-resistant strain of TB. A continuing social stigma for those who have TB is also linked to incomplete treatment and lack of follow-up. There is poor data collection as well. Since 2006, Operation ASHA (OpASHA) has helped deliver the Last-mile connection to TB treatment and prevention in India by leveraging existing government infrastructure to supplement the country’s own efforts. OpASHA receives free medicines, diagnostic facilities and physician services from the national TB control program. Through a partnership with Microsoft Research, OpASHA has pioneered a biometric technology called eCompliance for treatment. OpASHA serves 10 million people in nine states across India, in addition to 2.2 million people in Cambodia. OpASHA has expanded to Cambodia, and its model has already been replicated in Uganda, Kenya, and the Dominican Republic. 2017-07-31T22:24:49Z 2017-07-31T22:24:49Z 2017-04 Case Study http://documents.worldbank.org/curated/en/761511495104055640/OpASHA-improving-tuberculosis-treatment-and-outcomes http://hdl.handle.net/10986/27665 English en_US CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank World Bank, Washington, DC Publications & Research Publications & Research :: Working Paper South Asia India
repository_type	Digital Repository
institution_category	Foreign Institution
institution	Digital Repositories
building	World Bank Open Knowledge Repository
collection	World Bank
language	English en_US
topic	TUBERCULOSIS HEALTH TREATMENT MEDICINES DISEASES DIABETES
spellingShingle	TUBERCULOSIS HEALTH TREATMENT MEDICINES DISEASES DIABETES Agapitova, Natalia Navarrete Moreno, Cristina OpASHA : Improving Tuberculosis Treatment and Outcomes
geographic_facet	South Asia India
description	Tuberculosis (TB) afflicts 2.8 million citizens in India, representing more than 30 percent of the world’s total burden. To control TB, complete adherence to treatment is crucial—under the World Health Organization’s (WHO) Directly Observed Therapy Short-course (DOTS) strategy. In this strategy, patients are required to take up to 75 doses under supervision over six months at a treatment center or in the presence of an observer. However, the scarcity or inaccessibility of treatment centers and truthful observers in hard to-reach areas often results in high default rates. Missing a dose or interrupting treatment is extremely dangerous, since those who default can relapse, or much worse, develop the deadlier, drug-resistant strain of TB. A continuing social stigma for those who have TB is also linked to incomplete treatment and lack of follow-up. There is poor data collection as well. Since 2006, Operation ASHA (OpASHA) has helped deliver the Last-mile connection to TB treatment and prevention in India by leveraging existing government infrastructure to supplement the country’s own efforts. OpASHA receives free medicines, diagnostic facilities and physician services from the national TB control program. Through a partnership with Microsoft Research, OpASHA has pioneered a biometric technology called eCompliance for treatment. OpASHA serves 10 million people in nine states across India, in addition to 2.2 million people in Cambodia. OpASHA has expanded to Cambodia, and its model has already been replicated in Uganda, Kenya, and the Dominican Republic.
format	Case Study
author	Agapitova, Natalia Navarrete Moreno, Cristina
author_facet	Agapitova, Natalia Navarrete Moreno, Cristina
author_sort	Agapitova, Natalia
title	OpASHA : Improving Tuberculosis Treatment and Outcomes
title_short	OpASHA : Improving Tuberculosis Treatment and Outcomes
title_full	OpASHA : Improving Tuberculosis Treatment and Outcomes
title_fullStr	OpASHA : Improving Tuberculosis Treatment and Outcomes
title_full_unstemmed	OpASHA : Improving Tuberculosis Treatment and Outcomes
title_sort	opasha : improving tuberculosis treatment and outcomes
publisher	World Bank, Washington, DC
publishDate	2017
url	http://documents.worldbank.org/curated/en/761511495104055640/OpASHA-improving-tuberculosis-treatment-and-outcomes http://hdl.handle.net/10986/27665
_version_	1764464677792776192

OpASHA : Improving Tuberculosis Treatment and Outcomes

Similar Items